Serum alpha-1-antitriypsin levels in patients with pseudoexfolative syndrome

Current Eye Research

Volumn 33, Issue 2, 2008, Pages 159-162

  Cumurcu, Tongabay ^a   Ozyurt, Huseyin ^a   Demir, Helin Deniz ^a   Yardim, Huseyin ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Alpha 1 antitrypsin; Inflammation; Protease inhibitor; Pseudoexfoliation syndrome; Serum

Indexed keywords

ALPHA 1 ANTITRYPSIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOEXFOLIATION;

ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; EXFOLIATION SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY;

EID: 39749153410     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701861752     Document Type: Article

References (30)

1. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem. 1983;52:655-709.
2. Littleton ET, Bevis L, Hansen LJ, et al. Alpha-1-antitrypsin deficiency, complement activation, and chronic liver disease. J Clin Pathol. 1991;44:855-858.
3. Boskovic G, Twinning SS. Local control of alpha-1 proteinase inhibitor in the human cornea by growth factors and cytokines. Biochim Biopsy Acta. 1998;1403:37-46.
4. Ando H, Twinning SS, Yue BY, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci. 1993;34:3541-3548.
5. Clausen R, Weller M, Wiedeman P, et al. An immunochemical quantitative analysis of the protein pattern in physiologicand pathologic vitreous. Graefes Arch Clin Exp Ophthalmol. 1991;229:186-190.
6. Schlotzer-Schrehardt UM, Koca MR, Naumann GOH, et al. Pseudoexfoliation syndrome: Ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110:1752-1756.
7. Streeten BW, Li ZY, Wallace RN, et al. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110:1757-1762.
8. Damji KF, Bains HS, Stefansson E, et al. Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet. 1998;19:175-185.
9. Janciauskiene S, Krakau T. Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome. Doc Ophthalmol. 2003;106:215-223.
10. Schlotzer-Schrehardt U, Külche M, Dorfler S, et al. GOH. Pseudoexfoliative material in the eyelid skin of pseudoexfoliation-suspect patients: A clinico-histopathological correlation. Germ J Ophthalmol. 1993;2:51-60.
11. Fearnley IR, Spalton DJ, Ward AM, et al. Alpha-1-antitrypsin phenotypes in acute anterior uveitis. Br J Ophthalmol. 1988;72:636-639.
12. Evereklioglu C, Turkoz Y, Er H, et al. Increased nitric oxide production in patients with Behcet's disease: >s it a new activity marker? J Am Acad Dermatol. 2002;46:50-54.
13. Drolsum L, Haaskjold E, Sandvig K. Phacoemulsification in eyes with pseudoexfoliation. J Cataract Refract Surg. 1998;24:787-792.
14. Abela-Formanek C, Amon M, Schauersberger J, et al. Postoperative inflammatory response to phacoemulsification and implantation of 2 types of foldable intraocular lenses in pseudoexfoliation syndrome. Klin Monatsbl Augenheilkd. 2000;217:10-14.
15. Pierce JA. Antityripsin and emphysema. Perspective and prospects. JAMA. 1998;259:2890-2895.
16. Funding M, Vorum H, Nexo E, et al. Alpha-1-antitrypsin in aqueous humor from patients with corneal allograft rejection. Acta Ophthalmol Scand. 2005;83:379-384.
17. Evereklioglu C, Inaloz HS, Kirtak N, et al. Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activity. Br J Dermatol. 2002;147:331-336.
18. Janciauskiene S, Krakau T. Alzheimer's peptide: A possible link between glaucoma, exfoliation syndrome and Alzheimer's disease. Acta Ophthalmol Scand. 2001;79:328-329.
19. Giometto B, Argentiero V, Sanson F, et al. Acute-phase proteins in Alzheimer's disease. Eur Neurol. 1988;28:30-33.
20. Licastro F, Masliah E, Pedrini S et al. Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: Effects of gender and apolipoprotein E genotype. Dement Geriatr Cogn Disord. 2000;11:25-28.
21. Fiore PM, Melamed S, Epstein DL. Trabecular precipitates and elevated intraocular pressure following argon laser trabeculoplasty. Ophthalmic Surg. 1989;20:697-701.
22. Drolsum L, Davanger M, Haaskjold E. Risk factors for an inflammatory response after extracapsular cataract extraction and posterior chamber IOL. Acta Ophthalmol (Copenh). 1993;71:771-776.
23. Ritch R, Schlötzer-Screhardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.
24. Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B12 and folic acid levels in different types of glaucoma. BMC Ophthalmol. 2006;6:6.
25. Puustjarvi T, Blomster H, Kontkanae M, Punnonen K, Terasvirta M. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2004;242:749-754.
26. Yxfeldt A, Wallberg-Jonsson S, Hultdin J, Rantapaa-Dahlqvist S. Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand J Rheumatol. 2003;32:205-210.
27. Su SJ, Huang LW, Pai LS, Liu HW, Chang KL. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition. 2005;21:994-1002.
28. Holven KB, Aukrust P, Retterstol K, Hangve TA, Morkid L, Ose L, Nenseter MS. Scand J Clin Lab Invest. 2006;66:45-54.
29. Tso TK, Huang WN, Huang HY, Chang CK. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. Rheumatology. 2006;45:1148-1153.
30. Schlotzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141:921-937.